Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Apr 9, 2019
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help people quit smoking, focusing on how to manage feelings of withdrawal and negative emotions associated with quitting. Smoking is a major health issue, causing many deaths each year, so finding effective ways to help people stop is very important. The researchers hope this new method will improve the success rates of current smoking cessation programs, benefiting public health.
To participate in the trial, you must be at least 18 years old, smoke at least five cigarettes a day, and have a desire to quit. You also need to reside in the Birmingham area and have access to a phone. If you join, you can expect support and guidance as you work towards quitting smoking, while helping researchers learn more about effective quitting strategies. Remember, this study is currently recruiting participants, so if you meet the criteria and are interested, it could be a great opportunity to get help while contributing to important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at least 18 years of age
- • smoke at least 5 cigarettes per day
- • Expired breath carbon monoxide (CO) reading of at least five parts per million
- • report the intention to quit
- • reside in the Birmingham area with no plan to relocate outside of the area in the next 6 months
- • access to a telephone
- Exclusion Criteria:
- • inability to speak English
- • presence of a condition that contraindicates use of the nicotine patch
- • presence of conditions that might interfere with compliance with the protocol or greatly complicate treatment
- • any acutely life-threatening disease
- • concurrent participation in a formal treatment program for smoking cessation
- • current use of any pharmacotherapy for smoking cessation
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials